Elevated circulating interleukin-6 (IL-6) is associated with a poorer outcome in patients with acute ischemic stroke (AIS)5,6 and predicts recurrent stroke in patients with small vessel disease7. This evidence concerns the gene IL6 and androgen insensitivity syndrome.